Targeted nocturia diagnostics, from home.
Osmurix is designed to enable clinicians to objectively diagnose and monitor nocturia using 3-day urine osmolality profiling
The problem
Nocturia affects millions and is frequently misdiagnosed. Current workflows depend on subjective diaries and isolated lab snapshots, leading to trial-and-error treatment and poor outcomes.
Fragmented data
Single measurements fail to capture diurnal patterns and treatment response.
Trial-and-error therapy
Without objective profiles, clinicians often cycle therapies with limited feedback.
High system burden
Chronic symptoms drive repeat visits and unnecessary investigations.
See it in action
A closer look at Osmurix and the thinking behind objective, home-based nocturia diagnostics.
The Midnight Wake-Up Call
Understanding Urine Osmolality
The solution
Osmurix is developing a point-of-care urine osmolality reader and proprietary disposable cups to generate a 3-day osmolality profile at home. The system is engineered to provide clinicians with objective insights to differentiate nocturnal polyuria and monitor therapy response over time.
Objective profiling
Longitudinal osmolality profile supports nocturnal polyuria diagnosis and personalized management.
Patient-friendly protocol
Home-based sampling reduces friction while preserving clinical rigor.
Aligned economics
Under our D2P model, our recurring revenue is generated through the consumable, proprietary disposable urine cups.
How it works
Simple workflow designed for adoption in urology and nephrology clinics.
Clinician prescribes a 3-day profiling test.
Patient collects 5 samples/day using Osmurix cups.
Reader generates a 3-day urine osmolality profile.
Clinician uses results to diagnose and optimize treatment.
Proof & moat
Developed at Nanyang Technological University with clinical evaluation at Singapore General Hospital.
Clinical validation
Ongoing clinical evaluation with SGH for prototype validation.
Global IP coverage
Protected by five pending patent families across the US, Europe, China, Japan, and Singapore.
Platform potential
Companion diagnostic opportunities for therapy response stratification and monitoring.
Partners
We collaborate with hospitals, clinics, and pharmaceutical partners to improve outcomes and accelerate adoption.
Hospitals & clinics
Pilot sites for adoption, workflow integration, and outcomes evidence.
Pharma
Companion diagnostics for nocturia / LUTS therapies and post-market monitoring.
Distributors
Regional commercialization partners for scale across Asia-Pacific and Europe.
Contact
Interested in a pilot, partnership, or investment discussion? Get in touch.
© 2026 Osmurix Diagnostics. All rights reserved.